Working… Menu

24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease (ADAMANT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02579252
Recruitment Status : Completed
First Posted : October 19, 2015
Last Update Posted : November 14, 2019
Information provided by (Responsible Party):
Axon Neuroscience SE